Kristof V.
- Country
- Belgium
- Department
- Neurology
Research Overview
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Trial of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Trial of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
- A Phase 2, Parallel-Group, Dose-Range-Finding Study With Randomized Double-Blind Treatment and Open-Label Periods to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Narcolepsy Type 1
Data & Insights
Has run more than one trial at 24 of 59 partner sites.
Specializations
Sleep Disorders
This investigator specializes in the study of narcolepsy, including both Type 1 and Type 2 variants. Their research encompasses therapeutic approaches for managing sleep-wake cycle disorders and evaluating novel treatment options for patients affected by these conditions.
- Narcolepsy Type 1 and Type 2 management
- Sleep-wake cycle regulation
- Novel therapeutic interventions
Their work focuses on advancing treatment options and understanding long-term therapeutic outcomes in narcolepsy patients.
Neuromuscular Disorders
The investigator conducts research in generalized myasthenia gravis (gMG), an autoimmune neuromuscular disorder. Their work centers on evaluating innovative therapeutic approaches for managing this condition, with particular attention to treatments that may improve patients' daily living activities.
- Autoimmune neuromuscular conditions
- Quality of life assessments
- Innovative treatment modalities
The research involves evaluating treatments that target specific aspects of gMG pathophysiology to enhance patient outcomes.
Clinical Assessments
This investigator specializes in implementing and analyzing clinical assessment tools, particularly the Myasthenia Gravis-Activities of Daily Living (MG-ADL) scale. Their expertise includes evaluating treatment efficacy through standardized measurement tools and patient-reported outcomes.
- Functional assessment protocols
- Treatment response evaluation
- Patient outcome measures
Their work emphasizes the importance of comprehensive clinical assessment in therapeutic development.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.